SCHEMBL27466160

SCHEMBL27466160

Nc1ccc(Cl)c(C(=O)Nc2ccc(Cl)cc2)c1Cc1ccncc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 3/20 0.53
▸ MAPK1 P28482 1/20 0.50
▸ TYK2 P29597 3/20 0.49
▸ JAK2 O60674 2/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ KDR P35968 6/20 0.48
▸ FLT1 P17948 3/20 0.48
▸ NAMPT P43490 2/20 0.48
▸ LMNA P02545 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ NT5E P21589 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27485591 0.89 TYK2 (0.49) JAK1MAPK1TYK2CYP3A4KDR
SCHEMBL27484906 0.81 JAK2 (0.52) JAK1MAPK1TYK2JAK2KDR
SCHEMBL27486256 0.81 KDR (0.57) JAK1MAPK1TYK2JAK2KDR
SCHEMBL27465576 0.79 JAK2 (0.52) JAK1MAPK1TYK2JAK2KDR
SCHEMBL27486252 0.76 KDR (0.48) JAK1MAPK1TYK2JAK2KDR
SCHEMBL3516173 0.75 JAK1 (0.69) JAK1MAPK1TYK2JAK2CYP3A4
SCHEMBL27485942 0.73 MAPT (0.49) JAK1MAPK1TYK2JAK2KDR
SCHEMBL4978331 0.71 KDR (0.61) JAK1MAPK1TYK2JAK2CYP3A4
SCHEMBL27467102 0.70 SMN1; SMN2 (0.54) MAPK1KDRLMNAKMT2AKDM4E
SCHEMBL3515171 0.70 JAK1 (1.00) JAK1TYK2JAK2CYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN claimed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback